3.32
price down icon2.64%   -0.09
pre-market  Vorhandelsmarkt:  3.45   0.13   +3.92%
loading
Schlusskurs vom Vortag:
$3.41
Offen:
$3.39
24-Stunden-Volumen:
82,215
Relative Volume:
0.59
Marktkapitalisierung:
$76.84M
Einnahmen:
$270.52M
Nettoeinkommen (Verlust:
$-6.08M
KGV:
-11.28
EPS:
-0.2944
Netto-Cashflow:
$17.42M
1W Leistung:
+0.91%
1M Leistung:
-10.75%
6M Leistung:
-30.40%
1J Leistung:
-14.65%
1-Tages-Spanne:
Value
$3.31
$3.3995
1-Wochen-Bereich:
Value
$3.25
$3.50
52-Wochen-Spanne:
Value
$2.90
$6.85

Petmed Express Inc Stock (PETS) Company Profile

Name
Firmenname
Petmed Express Inc
Name
Telefon
(561) 426-4444
Name
Adresse
420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Name
Mitarbeiter
287
Name
Twitter
@1800petmeds
Name
Nächster Verdiensttermin
2025-06-10
Name
Neueste SEC-Einreichungen
Name
PETS's Discussions on Twitter

Vergleichen Sie PETS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Pharmaceutical Retailers icon
PETS
Petmed Express Inc
3.32 76.84M 270.52M -6.08M 17.42M -0.2944
Pharmaceutical Retailers icon
WBA
Walgreens Boots Alliance Inc
11.52 9.81B 151.95B -5.78B 571.00M -6.69
Pharmaceutical Retailers icon
HITI
High Tide Inc
2.35 187.78M 376.07M -22.41M 18.73M -0.298
Pharmaceutical Retailers icon
WGRX
Wellgistics Health Inc
0.912 102.04M 0 0 0 0.00
Pharmaceutical Retailers icon
HKPD
Hong Kong Pharma Digital Technology Holdings Ltd
1.3583 21.78M 0 0 0 0.00

Petmed Express Inc Stock (PETS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-05-25 Eingeleitet Lake Street Buy
2022-01-20 Hochstufung Sidoti Neutral → Buy
2021-11-18 Eingeleitet Morgan Stanley Underweight
2021-10-01 Eingeleitet Jefferies Hold
2021-08-05 Fortgesetzt Credit Suisse Underperform
2021-06-03 Herabstufung Sidoti Buy → Neutral
2021-03-05 Hochstufung Sidoti Neutral → Buy
2021-01-27 Herabstufung Sidoti Buy → Neutral
2020-08-19 Hochstufung Sidoti Neutral → Buy
2020-04-09 Herabstufung Sidoti Buy → Neutral
2020-03-12 Hochstufung Sidoti Neutral → Buy
2020-02-24 Herabstufung Sidoti Buy → Neutral
2019-08-16 Herabstufung Craig Hallum Buy → Hold
2018-06-15 Eingeleitet CL King Neutral
2017-08-24 Hochstufung Sidoti Neutral → Buy
2017-07-24 Hochstufung Northcoast Neutral → Buy
2016-05-09 Hochstufung Craig Hallum Sell → Hold
2016-02-04 Eingeleitet Credit Suisse Underperform
2010-07-19 Herabstufung CL King Strong Buy → Accumulate
2010-07-19 Bestätigt JMP Securities Mkt Outperform
2010-05-25 Herabstufung Wedbush Neutral → Underperform
2010-05-06 Bestätigt Wedbush Neutral
2010-03-23 Herabstufung Janney Mntgmy Scott Buy → Neutral
2010-03-18 Herabstufung Piper Jaffray Overweight → Neutral
2010-02-16 Bestätigt CL King Strong Buy
2009-07-21 Hochstufung Piper Jaffray Neutral → Overweight
2009-01-07 Eingeleitet CL King Strong Buy
Alle ansehen

Petmed Express Inc Aktie (PETS) Neueste Nachrichten

pulisher
Jul 12, 2025

PetMed Express (PETS): Red Flags in Delayed Reporting Signal Governance and Fraud Risks - AInvest

Jul 12, 2025
pulisher
Jul 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc.PETS - WV News

Jul 12, 2025
pulisher
Jul 07, 2025

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

2025-07-07 | PetMed Express Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm's Investigation | NDAQ:PETS | Press Release - Stockhouse

Jul 07, 2025
pulisher
Jul 03, 2025

Silvercape investments buys Petmed Express (PETS) shares worth $9,070 By Investing.com - Investing.com

Jul 03, 2025
pulisher
Jul 03, 2025

PetMed Express Faces Nasdaq Filing Compliance Notice - TipRanks

Jul 03, 2025
pulisher
Jul 03, 2025

PetMeds receives Nasdaq non-compliance notice over delayed annual report By Investing.com - Investing.com Nigeria

Jul 03, 2025
pulisher
Jul 03, 2025

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K - TradingView

Jul 03, 2025
pulisher
Jul 03, 2025

PetMed Express Secures Critical Nasdaq Timeline: What This Means for PETS Stock Listing - Stock Titan

Jul 03, 2025
pulisher
Jul 02, 2025

Wagmo Collabs With PetMeds for Pet Benefits for Employees, Travel + Leisure Co. Pa - Loyalty360

Jul 02, 2025
pulisher
Jul 01, 2025

PetMeds delays 10-K filing amid whistleblower investigation By Investing.com - Investing.com Canada

Jul 01, 2025
pulisher
Jul 01, 2025

PETS Investor ALERT: Block & Leviton Investigating PetMed Express For Possible Securities ... - Bluefield Daily Telegraph

Jul 01, 2025
pulisher
Jul 01, 2025

PetMed Express, Inc. Provides Update on Fourth Quarter and FY 2025 Results Amid Audit Investigation - Quiver Quantitative

Jul 01, 2025
pulisher
Jun 26, 2025

PETMED ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Jun 26, 2025
pulisher
Jun 25, 2025

PetMed Express Under Scrutiny: How Delayed Financial Reporting Signals Investor Risk - AInvest

Jun 25, 2025
pulisher
Jun 24, 2025

Wagmo Partners with PetMeds® to Bring Everyday Pet Health Savings to Members - New Castle News

Jun 24, 2025
pulisher
Jun 23, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed ... - Bluefield Daily Telegraph

Jun 23, 2025
pulisher
Jun 21, 2025

PetMed Express (NASDAQ:PETS) Rating Lowered to “Sell” at Wall Street Zen - Defense World

Jun 21, 2025
pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 17, 2025

PetMeds reports preliminary Q4 sales decline, delays annual filing By Investing.com - Investing.com India

Jun 17, 2025
pulisher
Jun 17, 2025

PetMed Express sees Q4 net sales between $51.1M and $53.1M - MSN

Jun 17, 2025
pulisher
Jun 16, 2025

PetMed Express Delays Filing of Annual Report - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

PetMed Express (PETS) Projects Decline in Q4 Sales and Earnings - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

PetMed Express Inc (PETS) Q4 2025 Earnings: Revenue Misses Estimate at $51.1M-$53.1M, Net Loss Widens - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25 - The Manila Times

Jun 16, 2025
pulisher
Jun 16, 2025

PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25 | PETS Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

PETS Reports Expected Drop in Q4 Net Sales and Increased Net Loss | PETS Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Petmed Express, Inc. Announces Preliminary Fourth Quarter And FY 2025 Results And Filing Of Form 12B-25 - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

PetMeds Reports Major Revenue Drop and Delayed Filing: Q4 Sales Plunge $15M as Losses Double - Stock Titan

Jun 16, 2025
pulisher
Jun 16, 2025

PETS Reports Expected Drop in Q4 Net Sales and Increased Net Los - GuruFocus

Jun 16, 2025
pulisher
Jun 15, 2025

PetMed Express (PETS) Awaits Q4 Earnings with Improved EPS Outlo - GuruFocus

Jun 15, 2025
pulisher
Jun 11, 2025

Bank of America Corp DE Grows Stake in PetMed Express, Inc. (NASDAQ:PETS) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call - The Manila Times

Jun 11, 2025
pulisher
Jun 10, 2025

Dog Owner Defends Tick Meds Suit Against Elanco, Retailers - Law360

Jun 10, 2025
pulisher
Jun 10, 2025

PetMeds delays Q4 and fiscal 2025 earnings release By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

PetMed Express (PETS) Shares Fall Amid Financial Results Delay - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

PetMed Express Delays Fiscal Q4 Results - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

PetMed Express delays FQ4 results (PETS:NASDAQ) - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

PetMeds delays Q4 and fiscal 2025 earnings release - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

PetMed Express, Inc. Announces Delay in Fourth Quarter and Fisca - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

PetMed Express Delays 4Q Financial Report - MarketWatch

Jun 10, 2025
pulisher
Jun 10, 2025

PetMed Express Announces Delay in Q4 and Fiscal Year Results - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

PetMeds Earnings Release Postponed: Extended Audit Process Raises Questions About Q4 Results - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

PetMed Express, Inc. (NASDAQ:PETS) Stock Holdings Boosted by Squarepoint Ops LLC - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

PetMed Express: Navigating Near-Term Headwinds for Long-Term Growth Potential - AInvest

Jun 10, 2025
pulisher
Jun 09, 2025

Earnings To Watch: PetMed Express Inc (PETS) Reports Q4 2025 Result - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Earnings To Watch: PetMed Express Inc (PETS) Reports Q4 2025 Res - GuruFocus

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Advisers LP Sells 62,400 Shares of PetMed Express, Inc. (NASDAQ:PETS) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Millennium Management LLC Has $695,000 Stock Position in PetMed Express, Inc. (NASDAQ:PETS) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Jane Street Group LLC Cuts Holdings in PetMed Express, Inc. (NASDAQ:PETS) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Major Investment Alert: NINA CAPITAL HOLDINGS INC. Boosts Stake in Petmed Express! - TipRanks

Jun 04, 2025

Finanzdaten der Petmed Express Inc-Aktie (PETS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Petmed Express Inc-Aktie (PETS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Silvercape Investments Ltd
10% Owner
Jul 01 '25
Buy
3.21
694
2,228
2,308,413
NINA CAPITAL HOLDINGS INC.
10% Owner
Jun 03 '25
Buy
3.94
25,000
98,375
2,550,000
NINA CAPITAL HOLDINGS INC.
10% Owner
May 21 '25
Buy
3.86
25,000
96,500
2,525,000
Silvercape Investments Ltd
10% Owner
May 20 '25
Buy
3.95
7,401
29,234
2,307,719
Campos Sandra Yvette
CEO & President
Apr 30 '25
Sale
3.31
60,463
200,090
578,524
NINA CAPITAL HOLDINGS INC.
10% Owner
Mar 18 '25
Buy
4.08
100,000
408,500
2,500,000
NINA CAPITAL HOLDINGS INC.
10% Owner
Mar 10 '25
Buy
4.11
100,000
411,000
2,400,000
NINA CAPITAL HOLDINGS INC.
10% Owner
Mar 03 '25
Buy
4.33
50,000
216,250
2,300,000
NINA CAPITAL HOLDINGS INC.
10% Owner
Feb 03 '25
Buy
4.82
25,000
120,500
2,250,000
NINA CAPITAL HOLDINGS INC.
10% Owner
Jan 24 '25
Buy
4.95
25,000
123,675
2,200,000
$0.912
price down icon 8.80%
$1.3583
price down icon 0.13%
$1.59
price down icon 3.05%
pharmaceutical_retailers SSY
$0.9717
price down icon 1.84%
$1.06
price down icon 10.92%
Kapitalisierung:     |  Volumen (24h):